Lymphoid Malignancies Treatment Developments - Replacement of Bleomycin with Brentuximab Vedotin

Lymphoid Malignancies Treatment Developments - Replacement of Bleomycin with Brentuximab Vedotin

User Photo
ASHReport

2 years
7 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
John M Burke, MD from Rocky Mountain Cancer Centers discusses lymphoid malignancies treatment developments and replacement of Bleomycin with Brentuximab Vedotin at the 2017 American Society of Hematology.
Up Next Autoplay
>